SGP – spyglass pharma, inc. (US:NASDAQ)
Stock Stats
News
Spyglass Pharma (SGP) is now covered by HC Wainwright. They set a "buy" rating and a $37.00 price target on the stock.
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System [Yahoo! Finance]
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
Spyglass Pharma (SGP) was upgraded by Zacks Research to "hold".
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit [Yahoo! Finance]
Form 8-K SpyGlass Pharma, Inc. For: Mar 09
Form SCHEDULE 13G SpyGlass Pharma, Inc. Filed by: Samsara BioCapital, L.P.
Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: New Enterprise Associates 17, L.P.
Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: Gilde Healthcare Holding B.V.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.